Yüklüyor......
Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial
Background: Infants below 28 weeks' gestation have low thyroid hormone plasma levels compared with more mature infants and this may contribute to their risk of developmental disability. We aimed at determining the effect of supplementation with levothyroxine (LT4) for extremely premature infant...
Kaydedildi:
| Yayımlandı: | Thyroid |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Mary Ann Liebert, Inc., publishers
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7374616/ https://ncbi.nlm.nih.gov/pubmed/32070246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2019.0293 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|